GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 112 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,364,000 | +22633.3% | 57,057 | +12867.5% | 0.04% | – |
| Q2 2020 | $6,000 | +50.0% | 440 | -46.9% | 0.00% | – |
| Q4 2019 | $4,000 | -33.3% | 828 | -14.8% | 0.00% | – |
| Q3 2019 | $6,000 | -64.7% | 972 | -63.0% | 0.00% | -100.0% |
| Q2 2019 | $17,000 | +41.7% | 2,626 | +60.3% | 0.00% | 0.0% |
| Q1 2019 | $12,000 | +33.3% | 1,638 | -11.0% | 0.00% | 0.0% |
| Q4 2018 | $9,000 | -35.7% | 1,840 | -1.3% | 0.00% | 0.0% |
| Q3 2018 | $14,000 | -22.2% | 1,865 | -42.6% | 0.00% | 0.0% |
| Q1 2018 | $18,000 | +500.0% | 3,248 | +364.0% | 0.00% | – |
| Q4 2017 | $3,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
| Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
| Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
| Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
| Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
| Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
| WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |